Share Capital (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
|---|
| Equity [Abstract] |
|
| Summary Of Warrants Activity |
The following table summarizes certain information in respect of the Company’s warrants:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 |
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
Weighted Average
Exercise Price (C$) |
|
|
|
|
|
Weighted Average
Exercise Price (C$) |
|
Warrants outstanding, beginning |
|
|
22,640 |
|
|
$ |
3.56 |
|
|
|
49,236 |
|
|
$ |
4.06 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited |
|
|
(17,955 |
) |
|
|
2.52 |
|
|
|
— |
|
|
|
— |
|
Expired |
|
|
(4,685 |
) |
|
|
7.53 |
|
|
|
(26,596 |
) |
|
|
3.84 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants outstanding, ending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary Of Assumptions Used To Record Fair Value of Warrants |
As of December 31, 2022 and 2021, w a rrants classified as derivative liabilities on the consolidated balance sheets were revalued with the following inputs:
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
Risk-free interest rate |
|
|
— |
|
|
|
0.9 |
% |
Expected dividend yield |
|
|
— |
|
|
|
0.0 |
% |
Expected volatility |
|
|
— |
|
|
|
93.7 - 297.1 |
% |
Expected life |
|
|
— |
|
|
|
0.9 years |
|
|
| Schedule Of Warrants Outstanding |
Full share equivalent warrants outstanding and exercisable are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 |
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
Weighted Average
Exercise Price (C$) |
|
|
|
|
|
Weighted Average
Exercise Price (C$) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
— |
|
|
|
— |
|
|
|
20,855 |
|
|
|
3.47 |
|
2023 |
|
|
— |
|
|
|
— |
|
|
|
1,785 |
|
|
|
4.57 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary Of Potentially Dilutive Securities |
The following table summarizes potentially dilutive securities, and the resulting common share equivalents outstanding as of December 31, 202 2 and 2021:
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
Common share options |
|
|
7,877 |
|
|
|
10,504 |
|
Restricted stock units |
|
|
173,230 |
|
|
|
— |
|
Warrants |
|
|
— |
|
|
|
22,640 |
|
Secured notes |
|
|
— |
|
|
|
46,458 |
|
Debentures |
|
|
— |
|
|
|
10,135 |
|
MPX dilutive instruments (1)
|
|
|
— |
|
|
|
408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary Of Option Activity |
The following table summarizes certain information in respect of option activity under the Company’s stock option plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 |
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
Weighted Average Exercise Price (1)
|
|
|
Weighted
Average
Contractual
Life |
|
|
|
|
|
Weighted Average Exercise Price (1)
|
|
|
Weighted
Average
Contractual
Life |
|
Options outstanding, beginning |
|
|
10,504 |
|
|
$ |
3.65 |
|
|
|
— |
|
|
|
11,510 |
|
|
$ |
3.59 |
|
|
|
— |
|
Granted |
|
|
7,877 |
|
|
|
0.05 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cancellations |
|
|
(7,111 |
) |
|
|
3.47 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeitures |
|
|
(3,152 |
) |
|
|
4.32 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Expirations |
|
|
(241 |
) |
|
|
0.89 |
|
|
|
— |
|
|
|
(1,006 |
) |
|
|
2.92 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, ending (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
The Original Awards are denominated in Canadian dollars. Exercise prices have been converted to U.S. dollar equivalents using an exchange rate of CAD$1.3544 to $1.00 as of December 31, 2022 and December 31, 2021. |
| (2) |
As of December 31, 2022, 6,564 of the stock options outstanding were exercisable (December 31, 202 1
9,922). |
|
| Summary Of Black Scholes Option Pricing Model |
The Company used the Black-Scholes option pricing model to estimate the fair value of the options at the grant date using the following ranges of assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
3.8 |
% |
|
|
— |
|
Expected dividend yield |
|
|
0.0 |
% |
|
|
— |
|
Expected volatility |
|
|
128.6 |
% |
|
|
— |
|
Expected life |
|
|
4.3 years |
|
|
|
— |
|
|
| Summary Of Restricted Stock Units Activity |
The following table summarizes certain information in respect of RSU activity during the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31, 2022 |
|
|
Year Ended
December 31, 2021 |
|
|
|
|
|
|
Weighted Average Grant Price (1)
|
|
|
|
|
|
Weighted
Average
Grant
Price |
|
Unvested balance, beginning |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Granted |
|
|
474,557 |
|
|
|
0.08 |
|
|
|
— |
|
|
|
— |
|
Vested |
|
|
(263,155 |
) |
|
|
0.09 |
|
|
|
— |
|
|
|
— |
|
Forfeited |
|
|
(81,731 |
) |
|
|
0.10 |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested balance, ending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average grant price is presented in U.S. dollars for the year ended December 31, 2022. |
|